Andrew H. Lane - 15 Nov 2021 Form 4 Insider Report for ABBOTT LABORATORIES (ABT)

Role
EXECUTIVE VICE PRESIDENT
Signature
/s/ Andrew H. Lane by Jessica H. Paik, Attorney-in-Fact, Attorney-in-Fact
Issuer symbol
ABT
Transactions as of
15 Nov 2021
Net transactions value
-$1,300,090
Form type
4
Filing time
17 Nov 2021, 17:22:31 UTC
Previous filing
31 Aug 2021
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ABT Common shares without par value Sale $1,300,090 -10,000 -12% $130.01 76,087 15 Nov 2021 Direct F1
holding ABT Common shares without par value 1,543 15 Nov 2021 Profit Sharing Trust F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $130.00 to $130.03, inclusive. The reporting person undertakes to provide to Abbott Laboratories, any security holder of Abbott Laboratories, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
F2 Balance in the Abbott Laboratories Stock Retirement Trust as of November 15, 2021.

Remarks:

These transactions were made pursuant to a previously adopted plan complying with Rule 10b5-1(c).